Joceline V Vu1, Arden M Morris2, Lillias H Maguire3, Ana C De Roo3, Anudeep Mukkamala3, John C Krauss4, Scott E Regenbogen3, Samantha Hendren3, Karin M Hardiman5. 1. Department of Surgery, University of Michigan, United States. Electronic address: vuj@med.umich.edu. 2. S-SPIRE Center, Department of Surgery, Stanford University, United States. 3. Department of Surgery, University of Michigan, United States. 4. Division of Hematology/Oncology, Department of Internal Medicine, and Department of Learning Health Sciences, University of Michigan, United States. 5. Department of Surgery, University of Alabama, United States.
Abstract
BACKGROUND: Multidisciplinary cancer clinics deliver streamlined care and facilitate collaboration between specialties. We described patient volume and specialty service utilization, including surgery, of a multidisciplinary colorectal cancer clinic established at a tertiary care academic institution. METHODS: We conducted a retrospective observational cohort study of adult patients with colorectal adenocarcinoma from 2012 to 2017. We performed a descriptive analysis of patient volume, percentage of rectal cancer patients, and the number of patients who saw and received surgery, chemotherapy, and radiation each year. RESULTS: Over 5 years, 1711 patients were served at the multidisciplinary clinic. Patient volume increased 37%, from n = 228 (annualized) to n = 312. The percentage of rectal cancer patients increased from 29% in 2013 to 42% in 2017. The highest rate of utilization was for surgery; 792 (46%) patients had surgery at the multidisciplinary clinic institution, and 510 (30%) received chemotherapy there. Out of 635 rectal cancer patients, 114 (18%) received radiation there. CONCLUSIONS: Over the five-year experience of a colorectal cancer-focused multidisciplinary clinic, overall patient volume increased by 37%. Over the study period, 63% of patients seen at the multidisciplinary clinic ultimately received at least one treatment modality at the clinic institution. Overall, the clinic's establishment resulted in the increased referral of complex patients.
BACKGROUND: Multidisciplinary cancer clinics deliver streamlined care and facilitate collaboration between specialties. We described patient volume and specialty service utilization, including surgery, of a multidisciplinary colorectal cancer clinic established at a tertiary care academic institution. METHODS: We conducted a retrospective observational cohort study of adult patients with colorectal adenocarcinoma from 2012 to 2017. We performed a descriptive analysis of patient volume, percentage of rectal cancer patients, and the number of patients who saw and received surgery, chemotherapy, and radiation each year. RESULTS: Over 5 years, 1711 patients were served at the multidisciplinary clinic. Patient volume increased 37%, from n = 228 (annualized) to n = 312. The percentage of rectal cancer patients increased from 29% in 2013 to 42% in 2017. The highest rate of utilization was for surgery; 792 (46%) patients had surgery at the multidisciplinary clinic institution, and 510 (30%) received chemotherapy there. Out of 635 rectal cancer patients, 114 (18%) received radiation there. CONCLUSIONS: Over the five-year experience of a colorectal cancer-focused multidisciplinary clinic, overall patient volume increased by 37%. Over the study period, 63% of patients seen at the multidisciplinary clinic ultimately received at least one treatment modality at the clinic institution. Overall, the clinic's establishment resulted in the increased referral of complex patients.
Authors: Erika A Newman; Amy B Guest; Mark A Helvie; Marilyn A Roubidoux; Alfred E Chang; Celina G Kleer; Kathleen M Diehl; Vincent M Cimmino; Lori Pierce; Daniel Hayes; Lisa A Newman; Michael S Sabel Journal: Cancer Date: 2006-11-15 Impact factor: 6.860
Authors: Leonard G Gomella; Jianqing Lin; Jean Hoffman-Censits; Patricia Dugan; Fran Guiles; Costas D Lallas; Jaspreet Singh; Peter McCue; Timothy Showalter; Richard K Valicenti; Adam Dicker; Edouard J Trabulsi Journal: J Oncol Pract Date: 2010-11 Impact factor: 3.840
Authors: J H Chang; E Vines; H Bertsch; D L Fraker; B J Czerniecki; E F Rosato; T Lawton; E F Conant; S G Orel; L Schuchter; K R Fox; N Zieber; J H Glick; L J Solin Journal: Cancer Date: 2001-04-01 Impact factor: 6.860
Authors: Arden M Morris; Kevin G Billingsley; Awori J Hayanga; Barbara Matthews; Laura-Mae Baldwin; John D Birkmeyer Journal: J Natl Cancer Inst Date: 2008-05-13 Impact factor: 13.506
Authors: Al B Benson; Alan P Venook; Mahmoud M Al-Hawary; Lynette Cederquist; Yi-Jen Chen; Kristen K Ciombor; Stacey Cohen; Harry S Cooper; Dustin Deming; Paul F Engstrom; Jean L Grem; Axel Grothey; Howard S Hochster; Sarah Hoffe; Steven Hunt; Ahmed Kamel; Natalie Kirilcuk; Smitha Krishnamurthi; Wells A Messersmith; Jeffrey Meyerhardt; Mary F Mulcahy; James D Murphy; Steven Nurkin; Leonard Saltz; Sunil Sharma; David Shibata; John M Skibber; Constantinos T Sofocleous; Elena M Stoffel; Eden Stotsky-Himelfarb; Christopher G Willett; Evan Wuthrick; Kristina M Gregory; Lisa Gurski; Deborah A Freedman-Cass Journal: J Natl Compr Canc Netw Date: 2018-07 Impact factor: 11.908
Authors: Debasish Sundi; Jason E Cohen; Alexander P Cole; Brian P Neuman; John Cooper; Farzana A Faisal; Ashley E Ross; Edward M Schaeffer Journal: Prostate Date: 2014-10-13 Impact factor: 4.104
Authors: Megan J McKee; Kevin Keith; Allison M Deal; Amy L Garrett; Amy A Wheless; Rebecca L Green; Julie M Benbow; E Claire Dees; Lisa A Carey; Matthew G Ewend; Carey K Anders; Timothy M Zagar Journal: Oncologist Date: 2015-12-09
Authors: Hyrum S Eddington; Megan McLeod; Amber W Trickey; Nicolas Barreto; Katherine Maturen; Arden M Morris Journal: Cancer Med Date: 2021-05-01 Impact factor: 4.452
Authors: Sarah A Wall; Erin Stevens; Jennifer Vaughn; Naresh Bumma; Ashley E Rosko; Uma Borate Journal: Curr Hematol Malig Rep Date: 2022-01-13 Impact factor: 4.213